Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Novo Nordisk is lifting curbs on prescriptions of its weight-loss drug Wegovy in the United States and is increasing supply ...

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations and narrowed its 2024 full-year ...

Novo Nordisk’s total revenue in the third quarter missed analysts’ expectations but sales of weight loss drug Wegovy exceeded the consensus forecast. Still, the Danish drugmaker narrowed its full-year ...

“The approved doses are the only dose strengths that have ... that the shortage of Eli Lilly’s Zepbound was over, though Wegovy remains scarce. Eli Lilly then sent cease-and-desist letters ...

In interviews with Reuters, eight U.S. obesity specialists at universities and large health systems described a different ...

Below are highlights of comments by CEO Lars Fruergaard Jorgensen in an interview with Reuters: CONFIRMS THE COMPANY HAS LIFTED US CURBS ON LOWER DOSES OF WEGOVY IN PLACE SINCE MID-2023: "In our ...

The company narrowed its full-year guidance as its blockbuster weight-loss drug soars in popularity.

Novo Nordisk addresses safety concerns surrounding compounded versions of its weight-loss and diabetes drugs, including ...

The national use of weight loss drugs like Ozempic and Wegovy more than doubled as bariatric surgery frequency dropped by ...

Popular weight-loss drugs are helping some runners lose weight and crush PRs. Experts have some real concerns.